Las Vegas Stem Cell Therapy

Emerging medical procedures such as stem cell therapy offer hope for people with nagging knee, shoulder and hip pain that other, traditional treatments haven’t alleviated.

Stem Cell Therapy

Stem cells start out as blank slates, but have the unique ability to transform into specialized cells, whether bone, muscle, or organ, depending on the body’s needs. Because of their transformational abilities, stem cells have the power to help the body regenerate damaged areas, including knee cartilage.

This therapy has emerged in headlines recently, and sometimes generated controversy, but stem cells can come from adults or be collected at the time of birth without harming the mother or the baby.

This allows people to take advantage of this cutting-edge treatment without the ethical concerns.

One type of stem cell treatment that uses tissues gathered at birth is called amniotic tissue therapy. Amniotic tissue is especially helpful for patients looking for relief from knee pain because it contains connective tissue in addition to stem cells. When inserted into the knee, the connective tissue helps the body regenerate its own, healthy connective tissue and repair the damaged areas.

Because stem cells remain an integral part of healing and growth throughout a person’s lifetime, adults also have stem cells, although in lower quantities than found earlier in life. In adults, stem cells are often removed from the bone marrow, blood, or fat.

Stem cells found in adult bone marrow are called mesenchymal stem cells. These cells have the ability to transform into bone, cartilage, or cells involved with the growth of connective tissue, according to the National Institute of Health. Early research shows the cells help repair damage by encouraging healing, decreasing inflammation and helping patients regain mobility.

When stem cell therapy is used in an effort to alleviate knee, hip or shoulder pain, high concentrations of the cells are injected into the joint. In the case of adult stem cells, the material may come from the person needing treatment, called an autograft, or from an adult donor, called an allograft.

Stem Cell Therapy

PolyCyte™

Structural Wharton’s Jelly Allograft

PolyCyte™ is a minimally manipulated human tissue allograft derived from the Wharton’s Jelly of the umbilical cord. PolyCyte™ is processed to preserve cytokines, growth factors, proteins and structural integrity of Wharton’s jelly for homologous use.

Innovative Development

Predictive Biotech’s innovative human cell and tissue products are processed in our FDA registered lab. Our minimally manipulated tissue products are prepared utilizing proprietary extraction methods that reduce the loss of important structural proteins, cytokines and growth factors.

Quality Assurance

PolyCyte™ is processed from donated human tissue from full-term deliveries. Comprehensive medical and social histories of the donors are obtained and tissues are procured, processed, and tested in accordance with standards established by FDA requirements to minimize potential risks of disease transmission to recipients. Infectious disease testing is performed at a certified laboratory in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR part 493.

FDA Regulatory Compliance

Polycyte® is processed from donated human tissue from full term deliveries according to the American Association of Tissue Banks (AATB) standards, and is regulated as a human cell, tissue, or cellular or tissue-based product (HCT/P) under 21 CFR Part 1271 and Section 361 of the Public Health Service Act.

Stem Cell Therapy

Stem Cell Therapy

CoreCyte™

Structural Wharton’s Jelly Allograft

Innovative Development

Predictive Biotech’s innovative human cell and tissue products are processed in our FDA registered lab. Our minimally manipulated tissue products are prepared utilizing proprietary extraction methods that reduce the loss of important structural proteins, cytokines and growth factors.

Quality Assurance

CoreCyte™ is processed from donated human tissue from full-term deliveries. Comprehensive medical and social histories of the donors are obtained and tissues are procured, processed, and tested in accordance with standards established by FDA requirements to minimize potential risks of disease transmission to recipients. Infectious disease testing is performed at a certified laboratory in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR part 493.

FDA Regulatory Compliance

CoreCyte™ is regulated as a human cell and tissue product (HCT/P) under 21 CFR Part 1271 and Section 361 of the Public Health Service Act. CoreCyte™ is intended for homologous use.

Stem Cell Therapy

Schedule an appointment

By Phone: (702) 912-4100

Contact Us